Flu's up for Rockeby
Thursday, 24 July, 2008
Rockeby Biomed [ASX: RBY] has received international orders for its bird flu tests worth a combined $252,000.
Payments have already been received from several south-east Asian, European and north African countries, and orders are in the process of delivery over the next few weeks, the company said.
The timing of the new orders is serendipitous, as Rockeby recently announced it had withdrawn from a non-binding agreement it had reached with an unnamed south-east Asian country.
According to company spokespeople, the decision to withdraw was reached because Rockeby had not received the advance payments stipulated by the agreement.
Researchers genetically engineer snake antivenom
An international team of researchers has used genetic engineering to create so-called...
Common medications linked to adverse breast cancer outcomes
An international study has found concerning evidence about the impact of a range of common...
Saliva-based biosensor could improve heart failure detection
Scientists have created a biosensor that can rapidly detect the heart failure biomarker S100A7 in...
